Hindustan Bio Sciences Limited

₹6.71As of Sun 8 Nov 2026, 12:00 UTC
BSE:532041Healthcare
Country India
PE (Fwd) •••
TSR 10Y CAGR 14.03%
Div yield —
ROE 17.31%
Biological Products, Except Diagnostic Substances
Beta (5Y) (0.54)
PE TTM 41.47
TSR TTM (9.57%)
Mkt cap ₹68.78M
ROIC (6.75%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹6.99
4.11%
1.89%
Hold 12|12|8|3|8
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
0.08
0.09
0.09
0.10
18.59%
15.17%
12.25%
18.25%
Revenue₹M
10.66
10.82
10.89
10.65
20.36%
17.27%
11.83%
5.45%
Peers (US$0.710M)
Cap (US$)
PE
0.673M
7.964x
Capital
TTM
5Y
10Y
Leveragex
1.102
(0.261)
(0.256)
EBIT/Intx
2.252
1.025
0.797
Own earn%
(85.90)
(27.71)
(46.00)
Sh yield%
28.73
35.08
34.58
Owners
Insiders/Inst%
7.66
49.30
Short interest%
3.51
SBC / revenue%
4.78
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
17–27
$1 testx
0.4
Incr. ROIC%
8